SCHEDULE 13G

Company

Acumen Pharmaceuticals, Inc.

Filed

February 16, 2022

Accession Number

0001804348-22-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →